16 news items
Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
TEVA
4 Jun 24
to: our ability to successfully compete in the marketplace including our ability to successfully execute our Pivot to Growth strategy, including
Teva Announced Saturday, Switching To UZEDY At Four Weeks After The Last Dose Of Once-monthly Paliperidone Palmitate Provided The Most Comparable Pharmacokinetic Profile Based On The Relevant PK Modeling Data For Schizophrenia
TEVA
2 Jun 24
studies from its long-acting injectable (LAI) schizophrenia research program. Presentations include data informing clinical strategies for switching
New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)
TEVA
1 Jun 24
. Presentations include data informing clinical strategies for switching patients to UZEDY, an extended-release injectable suspension of risperidone
Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024
TEVA
1 Jun 24
strategy, including to expand our innovative and biosimilar medicines pipeline and profitably commercialize the innovative medicines and biosimilar portfolio
Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day)
TEVA
29 May 24
to develop and commercialize additional pharmaceutical products; our ability to successfully execute our Pivot to Growth strategy, including to expand
yi7luxhybxh73gcsg937r8644vkosj4a c7kjnj0gf9
ALVO
TEVA
20 May 24
to develop and commercialize additional pharmaceutical products; our ability to successfully execute our Pivot to Growth strategy, including to expand
8wc4729bac0jr904uox3z7xi m270xj
TEVA
15 May 24
strategy, Eric Drapé has played a key role in strengthening our operations network. During his tenure leading TGO, the organization has made tremendous
i1pm847u
ABNB
ANET
APP
8 May 24
analyst. Fund Strat Global Head of Technical Strategy Mark Newton said in a note on Monday equities remain in a new short-term bullish
v1qn24w9woij0j
TEVA
8 May 24
. Francis continued, "As we mark the first anniversary of our Pivot to Growth Strategy, I am proud of the significant strides we have been making
dse9o1u47yprb1ckvbr5zu8udp6h6hz3o9bvzw0hc
TEVA
8 May 24
pharmaceutical products; our ability to successfully execute our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline
1h55dh0qe7x4xkewt1l3rculrbicgdey6zkg9s2m6z3wms18sn o0pko
TEVA
2 May 24
the Company's renewed sustainability strategy, which guides Teva in addressing global challenges while also supporting its business, allowing
zjn70j
ALVO
TEVA
30 Apr 24
arrangements; (14) Alvotech's ability, and that of its commercial partners, to execute their commercialization strategy for approved products; (15) Alvotech's
nkyatswzp6rkonrnkkjdst5ekbaszotrk8rw bqlr964b
TEVA
11 Apr 24
; our ability to successfully execute our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and profitably
unl1ns5jh4ztc4rvtk16o4chqk43owah 9w7uer
TEVA
8 Apr 24
PK modeling data provide insights into potential dosing conversions and strategies for switching to UZEDY from a long-acting injectable
cs1rx5y52 794
TEVA
6 Apr 24
modeling data provide insights into potential dosing conversions and strategies for switching to UZEDY from a long-acting injectable (LAI) formulation
11ikdvzwtw32a9n7sporjzl32u60fz09ousdh8ofrd6rqt5zk11fl08s8b89
TEVA
4 Apr 24
Agreement signals a major step in mAbxience's global expansion strategy and advances a key
- Prev
- 1
- Next